Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service
The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid.
Buyer
NHS England
Value
£88,000
Published
12 Jan 2024
Closes
17 Mar 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
31 Mar 2023
Contract ends
31 Mar 2025
CPV classifications
85100000
Health services
Lots
Lot default Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service
£88,000
The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid.
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
12 Jan 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
nhs-terms-and-conditions-for-the-provision-of-services-po-version
Not provided
nhs-terms-and-conditions-for-the-provision-of-services-po-version
Contains public sector information licensed under the Open Government Licence v3.0.